Clinical Trial

Omega-3 Fatty Acids, Neuroendocrine and Attention Deficit Hyperactivity Disorder (OMNeADHD)

Study acronym: OMNeADHD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 26, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a 12 week randomized controlled study on the effects of omega-3 fatty acids in youth with attention deficit hyperactivity disorder (ADHD) with omega-3 deficiency.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-15.
Trial Details
NCT Number NCT07364331
Lead Sponsor China Medical University Hospital
Conditions ADHD, Children, Adolescents
Enrollment 100 participants
Start Date 2021-09-04
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-26